Botox vs. Tacrolimus for mild to moderate psoriasis
Treatments studied
Part of Skin clinical trials.
This trial compares Botox injections with tacrolimus cream to see which works better for mild to moderate psoriasis. It might help if you have had psoriasis for a while and haven't used other treatments recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mild to moderate plaque psoriasis (not covering more than 10% of your body).
- You have not used any oral psoriasis medications or light therapy for at least 3 months.
- You have not used any psoriasis creams for at least 4 weeks.
- You do not have neuromuscular disease or epilepsy.
- You are not pregnant or breastfeeding.
- You do not have any other current skin disease or serious medical condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a cream made from thymoquinone (a natural substance from black seed oil) to see if it can help treat mild psoriasis. If you have mild psoriasis and haven't used other treatments recently, you may be able to join.
This study compares two treatments for vitiligo: narrowband UVB light therapy combined with either tacrolimus ointment or calcipotriol ointment. It aims to see which combination works better and is safer for people with stable, limited vitiligo.
This trial tests whether Botox injections can improve eczema by calming nerve-immune system interactions. It is for adults with mild-to-moderate eczema who have not used certain stronger treatments recently.
This study compares two oral pill treatments—methotrexate and tofacitinib—for people with chronic plaque psoriasis that is moderate to severe and hasn't responded well to creams. The goal is to see which pill works better at clearing skin.
This trial tests whether crisaborole ointment works as well as tacrolimus ointment for children ages 2 to 18 with mild to moderate atopic dermatitis (eczema). If your child has eczema covering less than 30% of their body and hasn't used certain creams or medications recently, this study may be an option.
This study compares two systemic medications—methotrexate (a traditional immunosuppressant) and tofacitinib (a newer targeted therapy)—to see which works better for moderate-to-severe plaque psoriasis that hasn't responded well to creams or ointments.
Hear when a new Psoriasis Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.